Scavenging of Reactive Carbonyl Species by Dietary Flavonoids in Humans
NCT ID: NCT05773794
Last Updated: 2025-05-25
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2023-02-06
2023-12-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Scavenging of Reactive Carbonyl Species by Apple Polyphenols in Human
NCT03911050
Impact of Non Digestible Carbohydrate on Production of Phenolic Acids From Strawberry Juice
NCT03383809
Investigating the Acute Effects of Flavonoids in Blueberries on Cognitive Function.
NCT01289860
Effects of Tea Catechin Extracts on Oxidative Damage
NCT00448513
Effects of a Single Dose of Wild Blueberries on Mood and Executive Function in Healthy Emerging Adults
NCT05717452
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
On week 2, each of the eight participants received 460 ml of soymilk, green tea, and blueberry in a single dose, and afterward, urine and blood samples at different time points over 24 h and fecal samples at different time points over 48 h were collected. Meanwhile, the other eight participants received breakfast (without any soymilk, green tea, and blueberry) at different time points over 48 h were collected.
On the contrary, on week 3, eight participants who received regular milk or water on week 2 received breakfast only, and eight participants who were used as a control on week 2 received soymilk, green tea, and blueberry. And urine and blood samples at different time points over 24 h, and fecal samples at different time points over 48 h for both groups were collected.
Samples will be analyzed by LC-MS/MS. The Pharmacokinetics of conjugates will be investigated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dietary flavonoids (soymilk) consumption
Week 1: Sixteen healthy volunteers were recruited and instructed to avoid consuming soymilk, green tea, and blueberry products starting one week before the intervention and continuing throughout the entire 3-week study period.
Week 2: Participants consumed a breakfast including 460 mL of soymilk (or milk) in a single dose. Urine and blood samples were collected at multiple time points over 24 hours, and fecal samples were collected at different time points over 48 hours.
Week 3: Participants consumed a breakfast including 460 mL of milk (or soymilk) in a single dose. Urine and blood samples were collected at multiple time points over 24 hours, and fecal samples were collected at different time points over 48 hours.
Soymilk, green tea, or blueberry
One dose of soymilk, green tea, or blueberry blends (460mL) with breakfast.
Control group
Breakfast with milk or water, without soymilk, green tea, or blueberry blends.
Dietary flavonoids (blueberry) consumption
Week 1: Sixteen healthy volunteers were recruited and instructed to avoid consuming soymilk, green tea, and blueberry products starting one week before the intervention and continuing throughout the entire 3-week study period.
Week 2: Participants consumed a breakfast including 460 mL of blueberry water (or placebo sweet water) in a single dose. Urine and blood samples were collected at multiple time points over 24 hours, and fecal samples were collected at different time points over 48 hours.
Week 3: Participants consumed a breakfast including 460 mL of placebo sweet water (or blueberry water) in a single dose. Urine and blood samples were collected at multiple time points over 24 hours, and fecal samples were collected at different time points over 48 hours.
Soymilk, green tea, or blueberry
One dose of soymilk, green tea, or blueberry blends (460mL) with breakfast.
Control group
Breakfast with milk or water, without soymilk, green tea, or blueberry blends.
Dietary flavonoids (green tea) consumption
Week 1: Sixteen healthy volunteers were recruited and instructed to avoid consuming soymilk, green tea, and blueberry products starting one week before the intervention and continuing throughout the entire 3-week study period.
Week 2: Participants consumed a breakfast including 460 mL of green tea (or water) in a single dose. Urine and blood samples were collected at multiple time points over 24 hours, and fecal samples were collected at different time points over 48 hours.
Week 3: Participants consumed a breakfast including 460 mL of water (or green tea) in a single dose. Urine and blood samples were collected at multiple time points over 24 hours, and fecal samples were collected at different time points over 48 hours.
Soymilk, green tea, or blueberry
One dose of soymilk, green tea, or blueberry blends (460mL) with breakfast.
Control group
Breakfast with milk or water, without soymilk, green tea, or blueberry blends.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Soymilk, green tea, or blueberry
One dose of soymilk, green tea, or blueberry blends (460mL) with breakfast.
Control group
Breakfast with milk or water, without soymilk, green tea, or blueberry blends.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. BMI between 18 and 30
3. Have no known allergy to soy milk
4. Be not taking antibiotics for six months
5. Be not currently taking medication
1. No taking any prescription drugs
2. If supplements were taken, flavonoid-enriched supplements (see list below) should be avoided.
Major brands Notes: All flavonoid-enriched supplements should be avoided. Soy Isoflavones/ tea/blueberry Lipo-Flavonoid Citrus Bioflavonoids Complex Super Flavonoids Super Antioxidants Quercetin Supplement Essential-C and flavonoids Milk Thistle Other flavonoids supplements, including but not limited: Luteolin, Rutin, etc
3. No any drugs or supplements within three weeks of the experiment
6. Be nonsmoking
7. Have no alcoholic intoxication
1. No alcoholic addiction
2. \< 3-4 drinks per week (less than 2 glasses (300 mL) per drink)
3. No alcohol within 3 three weeks of the experiment
8. Have no extended exposure to industrial wastes
Exclusion Criteria
2. Cancer patients
1. Currently diagnosed cancer patients will be excluded;
2. Medication free for \>2 years could be considered;
25 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
North Carolina Agriculture & Technical State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shengmin Sang
Distinguished Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shengmin Sang, PhD
Role: PRINCIPAL_INVESTIGATOR
NC A&T State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
North Carolina Agriculture and Technical State University
Kannapolis, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-0093
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.